IS5821A - Kristalluð form af ósanetant - Google Patents

Kristalluð form af ósanetant

Info

Publication number
IS5821A
IS5821A IS5821A IS5821A IS5821A IS 5821 A IS5821 A IS 5821A IS 5821 A IS5821 A IS 5821A IS 5821 A IS5821 A IS 5821A IS 5821 A IS5821 A IS 5821A
Authority
IS
Iceland
Prior art keywords
unsanetant
crystalline form
crystalline
Prior art date
Application number
IS5821A
Other languages
English (en)
Inventor
Alcade Alain
Anne-Archard Gilles
Grosclaude Patrick
Monnier Olivier
Roche Jérôme
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of IS5821A publication Critical patent/IS5821A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS5821A 1998-08-05 2001-01-23 Kristalluð form af ósanetant IS5821A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9810107A FR2782082B3 (fr) 1998-08-05 1998-08-05 Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose
PCT/FR1999/001914 WO2000007987A1 (fr) 1998-08-05 1999-08-03 Formes cristallines du osanetant

Publications (1)

Publication Number Publication Date
IS5821A true IS5821A (is) 2001-01-23

Family

ID=9529458

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5821A IS5821A (is) 1998-08-05 2001-01-23 Kristalluð form af ósanetant

Country Status (31)

Country Link
US (1) US7041679B2 (is)
EP (1) EP1102747B1 (is)
JP (1) JP3807938B2 (is)
KR (1) KR100571944B1 (is)
CN (1) CN1114592C (is)
AR (1) AR019953A1 (is)
AT (1) ATE243197T1 (is)
AU (1) AU748177B2 (is)
BR (1) BR9913357A (is)
CA (1) CA2339007A1 (is)
CO (1) CO5070576A1 (is)
DE (1) DE69908951T2 (is)
DK (1) DK1102747T3 (is)
DZ (1) DZ3074A1 (is)
EA (1) EA003205B1 (is)
EE (1) EE04274B1 (is)
ES (1) ES2200535T3 (is)
FR (1) FR2782082B3 (is)
HU (1) HUP0103134A3 (is)
IS (1) IS5821A (is)
MY (1) MY121447A (is)
NO (1) NO320645B1 (is)
NZ (1) NZ509561A (is)
PL (1) PL345999A1 (is)
PT (1) PT1102747E (is)
SK (1) SK1742001A3 (is)
TR (1) TR200100261T2 (is)
TW (1) TW527354B (is)
UA (1) UA72890C2 (is)
WO (1) WO2000007987A1 (is)
YU (1) YU8601A (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100902D0 (sv) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
US7648992B2 (en) * 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
TW200800954A (en) * 2006-03-16 2008-01-01 Astrazeneca Ab Novel crystal modifications
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
US20240336565A1 (en) * 2021-07-02 2024-10-10 Acer Therapeutics, Inc. Solid forms of osanetant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
JPH1053576A (ja) * 1996-06-07 1998-02-24 Eisai Co Ltd 塩酸ドネペジルの多形結晶およびその製造法
EP0915849A2 (en) * 1996-08-05 1999-05-19 Smithkline Beecham S.p.A. Process for the preparation of 3,3-disubstituted piperidines
US6040316A (en) * 1996-09-16 2000-03-21 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines
FR2757543B1 (fr) * 1996-12-23 1999-04-02 Sanofi Sa Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues

Also Published As

Publication number Publication date
MY121447A (en) 2006-01-28
EE200100070A (et) 2002-06-17
KR100571944B1 (ko) 2006-04-18
CN1314888A (zh) 2001-09-26
JP3807938B2 (ja) 2006-08-09
EA200100096A1 (ru) 2001-08-27
HUP0103134A3 (en) 2003-03-28
SK1742001A3 (en) 2001-11-06
DK1102747T3 (da) 2003-09-29
ES2200535T3 (es) 2004-03-01
TW527354B (en) 2003-04-11
CA2339007A1 (en) 2000-02-17
NO20010553D0 (no) 2001-02-01
EA003205B1 (ru) 2003-02-27
NZ509561A (en) 2002-10-25
TR200100261T2 (tr) 2001-06-21
DE69908951D1 (de) 2003-07-24
BR9913357A (pt) 2001-05-15
PT1102747E (pt) 2003-09-30
FR2782082B3 (fr) 2000-09-22
DE69908951T2 (de) 2004-05-19
UA72890C2 (en) 2005-05-16
EP1102747A1 (fr) 2001-05-30
DZ3074A1 (fr) 2004-07-20
HUP0103134A2 (en) 2002-06-29
EP1102747B1 (fr) 2003-06-18
WO2000007987A1 (fr) 2000-02-17
JP2002522419A (ja) 2002-07-23
US7041679B2 (en) 2006-05-09
KR20010072220A (ko) 2001-07-31
AU748177B2 (en) 2002-05-30
PL345999A1 (en) 2002-01-14
CO5070576A1 (es) 2001-08-28
EE04274B1 (et) 2004-04-15
YU8601A (sh) 2003-07-07
US20040044215A1 (en) 2004-03-04
FR2782082A1 (fr) 2000-02-11
NO20010553L (no) 2001-04-05
AU5168599A (en) 2000-02-28
NO320645B1 (no) 2006-01-09
ATE243197T1 (de) 2003-07-15
AR019953A1 (es) 2002-03-27
CN1114592C (zh) 2003-07-16
HK1035535A1 (en) 2001-11-30

Similar Documents

Publication Publication Date Title
DK1107980T3 (da) Krystallinske former af EtO2C-CH2-(R)Cgl-Aze-Pab-OH
DK1064298T3 (da) Inhibitorer af caspaser
DK0991641T3 (da) Krystallinsk form af omeprazol-natriumsalt
DK1056444T3 (da) Stabile formede partikler af krystallinske organiske forbindelser
DK1169314T3 (da) Krystallinsk base af citalopram
IS5640A (is) Ný kristalla form af Bensímídazól efnasambandi gegn veirum
ID29021A (id) Komposisi galantamina pelepasan terkontrol
ID27092A (id) Pembuatan ftalat anhidrida
BR9711151A (pt) Forma cristalina de 4-¬5-metil-3-fenilsoxazol-4-il¾benzenossulfonamida
PT945132E (pt) Composicao de ibuprofeno
DK1149090T3 (da) Ny krystallinsk form af kaliumsalt af (S)-omeprazol
NO20020030D0 (no) Krystallinske 1-metylcarbapenemforbindelser
IT1312203B1 (it) Fusione di strisce
DK1280803T3 (da) Krystallinsk form II af cabergolin
NO20006255D0 (no) Krystallinsk efavirenz
DE69903524D1 (de) Pestizide hilfsmittel
DK1155050T3 (da) Fremstilling af polyolefin
IS6215A (is) Að mestu leyti kristallað form af melagatrani
IS5821A (is) Kristalluð form af ósanetant
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
IS5155A (is) Fjölgervingur af zópólrestat mónóhýdrati
FI980222A0 (fi) Stycke av isoleringsaemne med en genomgaoende primaerstroemledning
EE200100017A (et) N-tert-butüülhüdroksüülamiini uued soolad
DK1088010T3 (da) Fremstilling af polyolefiner
DK0927163T3 (da) Fremstilling af 1-butyl-4-piperidinylmethylamin